Bard PowerPort catheter fracture claims are now among the fastest-growing medical device cases in the federal courts. The PowerPort is an implanted port used to deliver chemotherapy, antibiotics, and IV fluids. Patients say the catheter tubing can crack, split, or break apart inside the body. Broken fragments may then travel to the heart or lungs. More than 3,500 lawsuits are pending in a single federal court in Arizona. This guide explains the science, the litigation status, and what injured patients should know.
- What Is a Bard PowerPort catheter fracture, and Why Are Patients Suing?
- MDL Case Status and Key Facts
- Who Qualifies for a Bard PowerPort Catheter Fracture Claim?
- How to File a Bard PowerPort Catheter Fracture Claim
- Settlement Updates and What to Expect
- State-by-State Considerations
- Frequently Asked Questions
Complete a short case review to see whether your diagnosis, Bard PowerPort implant history, and records may fit current attorney screening criteria. Submitting information does not guarantee representation, compensation, or participation in any lawsuit or settlement.
What Is a Bard PowerPort catheter fracture, and Why Are Patients Suing?
The Bard PowerPort is a totally implantable vascular access device. A small reservoir sits under the skin of the chest or arm. A thin catheter runs from that reservoir into a large central vein. Nurses access the port with a needle instead of finding a vein each visit. For cancer patients, that convenience matters enormously. However, the durability of the catheter tubing is now under serious scrutiny.
A Bard PowerPort catheter fracture typically involves the polymer tubing rather than the port body itself. Many PowerPort models use Chronoflex, a polyurethane blended with barium sulfate. Barium sulfate makes the catheter visible on X-ray imaging. Researchers at Germany’s BAM Federal Institute for Materials Research reported that barium sulfate particles can leach from the catheter surface. That leaching leaves microscopic pits. Plaintiffs argue those pits act as predetermined fracture sites under normal blood flow and body movement.
The alleged injuries are serious. Reported harms include catheter migration into the heart, cardiac arrhythmia, cardiac perforation, vein damage, blood clots, bloodstream infection, and sepsis. In some cases, surgeons must perform an endovascular retrieval to recover a loose fragment. Chemotherapy is often delayed as a result. The defendants are C.R. Bard, Inc., Bard Access Systems, Inc., and parent company Becton, Dickinson and Company. Bard denies that the devices are defectively designed.
Notably, the FDA has not issued a broad recall tied to this specific failure mode. A limited 2019 recall involved a small number of devices for unrelated reasons. Meanwhile, the FDA’s MAUDE adverse event database contains thousands of PowerPort reports describing fracture, migration, and infection.
Case Timeline
Last checked: July 23, 2026
- July 01, 2026 (Case Status): More than 3,300 cases remain pending in MDL 3081, with the next bellwether trial, the first involving a catheter fracture claim, set for August 18, 2026, and no global settlement reached. (Court Record)
- May 08, 2026 (Ruling): The jury in the first bellwether returned a defense verdict for Bard and Becton Dickinson on failure to warn, failure to instruct, and consumer fraud, but deadlocked on the design defect claim. (Court Record)
- April 21, 2026 (Bellwether Date): The first bellwether trial, Cook v. C.R. Bard/Becton Dickinson, an infection case, began before Judge Campbell in Phoenix. (Court Record)
- August 08, 2023 (Other): The JPML centralized federal Bard implanted port catheter lawsuits as MDL No. 3081 in the U.S. District Court for the District of Arizona before Judge David G. Campbell. (Court Record)
MDL Case Status and Key Facts
The Judicial Panel on Multidistrict Litigation centralized these cases on August 8, 2023. The consolidated proceeding is captioned In re: Bard Implanted Port Catheter Products Liability Litigation, MDL No. 3081.
| MDL Number | MDL No. 3081 |
|---|---|
| Official Case Name | In re: Bard Implanted Port Catheter Products Liability Litigation |
| Presiding Judge | Senior U.S. District Judge David G. Campbell |
| Federal District | U.S. District Court for the District of Arizona (Phoenix) |
| Centralization Date | August 8, 2023 |
| Approximate Pending Cases | 3,500+ as of July 2026 |
| Primary Defendants | C.R. Bard, Inc.; Bard Access Systems, Inc.; Becton, Dickinson and Company |
| First Bellwether Verdict | May 2026 — defense verdict on failure to warn; hung jury on design defect |
| Second Bellwether Trial | August 18, 2026 — first trial centered on a fracture claim |
| Additional Trial Settings | October 13, 2026; December 1, 2026; February 2, 2027 |
An MDL is not a class action. Each Bard PowerPort catheter fracture case remains a separate lawsuit with its own facts and damages. Judge Campbell handles discovery, expert challenges, and bellwether trials for all of them. Cases that do not resolve can be remanded to their home districts for trial. You can confirm current docket counts through the JPML pending MDL statistics page.
The May 2026 bellwether result was mixed. Jurors rejected the failure-to-warn theory but deadlocked on design defect. That outcome left the central engineering question unresolved. As a result, the August 2026 trial carries unusual weight. It is the first bellwether built around a fracture injury rather than infection. Both sides will read the verdict closely.
Who Qualifies for a Bard PowerPort Catheter Fracture Claim?
Eligibility generally starts with device identification. In most cases, a claimant must show that a Bard PowerPort or PowerPort ClearVUE device was implanted. Devices implanted from roughly 2000 forward have been included in filings. Medical records, implant cards, and operative reports usually establish this. Hospitals also keep device sticker logs in the surgical chart.
The second requirement is a qualifying injury. Typically, attorneys evaluate a Bard PowerPort catheter fracture that caused catheter migration, cardiac perforation, arrhythmia, thrombosis, deep vein clot, severe infection, sepsis, or emergency surgical removal. Minor irritation at the port site usually does not support a claim. For example, a fragment retrieved from the pulmonary artery is far stronger evidence than a simple port replacement.
Evidence matters more than device brand alone. Helpful documentation includes imaging that shows the fractured or migrated segment, interventional radiology reports, hospital admission records, and the explanted device if it was preserved. However, many patients never learn the manufacturer’s name. An attorney can request records directly from the implanting facility. Do not assume you are ineligible simply because you lack paperwork today.
How to File a Bard PowerPort Catheter Fracture Claim
The first step is a consultation with a licensed attorney experienced in medical device litigation. Most work on contingency, so there is no upfront fee. The lawyer will order your records and identify the exact device model. If the case qualifies, the complaint is usually filed directly into MDL 3081 under a direct-filing order. That approach saves months of transfer time.
Every plaintiff in a Bard PowerPort catheter fracture case must then complete a Plaintiff Fact Sheet. This sworn document covers your medical history, implant date, treating providers, and claimed injuries. Deadlines are strict. Incomplete fact sheets can lead to dismissal, so accuracy is essential. Your attorney will also collect authorizations for medical, pharmacy, and insurance records.
Statutes of limitations are the biggest trap. Deadlines vary by state and typically run two to four years. Many states apply a discovery rule that starts the clock when the injury is reasonably discovered. Some also impose a statute of repose. You can review the general framework at Cornell Legal Information Institute. Speak to a licensed attorney promptly rather than waiting for litigation news.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Settlement Updates and What to Expect
As of July 2026, there is no global settlement in MDL 3081. No settlement fund exists, and no payout matrix has been announced. Any website promising a specific check amount is not describing reality. Compensation in these cases varies widely and depends on individual facts.
Bellwether outcomes usually drive settlement talks in device litigation. The split May 2026 verdict gave neither side clear leverage. Consequently, the fall and winter 2026 trial settings become the real signal. A strong plaintiff verdict on design defect would likely accelerate negotiations. Conversely, repeated defense wins could push Bard to litigate case by case for years.
If a settlement program eventually forms, tiering typically reflects injury severity, surgical intervention, hospitalization length, permanent damage, treatment delay, age, and lost income. Comparative fault and state damage caps also matter. You may qualify for compensation if your records support a device-related fracture injury. However, nothing is guaranteed, and only a licensed attorney can assess your specific claim.
State-by-State Considerations
State law still governs the substance of each claim, even inside a federal MDL. Under Erie principles, the transferee court applies the law of the state where the case originated. That means tort reform rules follow your case. Texas caps noneconomic damages in some contexts and has strict expert report requirements. California applies a two-year limitations period with a discovery rule. Florida shortened its negligence limitations period in 2023. Pennsylvania and New York contribute large plaintiff counts because of dense cancer treatment networks.
Filing state also affects punitive damages availability and the government-contractor and preemption defenses Bard may raise. For example, some states bar punitive damages when a device cleared federal review. Review our state guides for Texas, California, Florida, Pennsylvania, and New York. A licensed attorney in your state can confirm which deadline applies to you.
Frequently Asked Questions
Was the Bard PowerPort recalled by the FDA?
No broad FDA recall has been issued for the catheter fracture issue. A small 2019 recall involved a limited number of units for unrelated reasons. Thousands of adverse event reports remain on file with the FDA, however.
How do I know if my port was a Bard PowerPort?
Check your implant card, operative report, or hospital device log. Many patients do not have these documents at home. An attorney can request them from the implanting hospital at no cost to you.
Is it too late to file a Bard PowerPort catheter fracture lawsuit in 2026?
Not necessarily, because deadlines depend on your state and when the injury was discovered. New cases are still being filed into MDL 3081. Consult a licensed attorney quickly, since waiting can permanently bar an otherwise valid claim.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Ohio Tort Reform Guide
- North Carolina Tort Reform Guide
- Georgia Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.
Complete a short case review to see whether your diagnosis, Bard PowerPort implant history, and records may fit current attorney screening criteria. Submitting information does not guarantee representation, compensation, or participation in any lawsuit or settlement.
Important: Legal deadlines can be time sensitive and vary by state, diagnosis date, exposure history, and other facts. Submitting information through this website does not file a lawsuit, preserve your rights, create an attorney-client relationship, or guarantee that any attorney will contact or represent you. If you do not receive a response, or if you are unsure about a filing deadline, you should promptly contact a qualified attorney of your choice to discuss your specific situation.
About this page: MassTortInfo.com is an informational publishing platform and a marketing / referral platform. We are not a law firm, settlement administrator, claims administrator, or government agency, and we do not provide legal advice. No attorney-client relationship is created by using this site or submitting any form. Submitting a form does not guarantee representation, compensation, eligibility, or participation in any lawsuit or settlement. This page contains paid advertising, and we may be compensated if you submit a case review. See our Terms of Service, Privacy Policy, and Disclaimer & Advertising Disclosure.